Eli Lilly and Company (NYSE:LLY) is one of the best pharma stocks to invest in now. Eli Lilly and Company (NYSE:LLY) announced on March 28 detailed results from the TOGETHER-PsA open-label Phase 3b ...
Please provide your email address to receive an email when new articles are posted on . Combination ixekizumab plus tirzepatide was superior to ixekizumab alone for improving active psoriatic ...
Taltz and Zepbound used together provided comprehensive improvements in disease activity and patient-reported outcomes compared to Taltz monotherapy in TOGETHER-PsA study Late-breaking results also ...
INDIANAPOLIS, March 28, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced detailed results from the TOGETHER-PsA open-label Phase 3b clinical trial evaluating the concomitant use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results